Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail
Team
Team
Sunday Briefing | #120 - by William Johnson
AbCellera Reports Q3 2022 Business Results
AbCellera Reports Full Year 2022 Business Results, Revenue up 29.3% to US $485 Million | T-Net News
Carl Hansen Receives the 2021 Bloom Burton Award
How EY Entrepreneur Of The Year 2021 winner AbCellera is building a biotech powerhouse - The Globe and Mail
Beyond COVID-19: AbCellera Partners with Moderna to Develop mRNA-Encoded Antibodies
Novartis Creates "Inflection Point" for AbCellera with 10-Target Antibody Collaboration
AbCellera Biologics Inc. - AbCellera Reports Q1 2023 Business Results
Carl Hansen - Chief Executive Officer - AbCellera | LinkedIn
AbCellera Appoints Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel | Financial Post
Meet Carl Hansen, the scientist-turned-CEO behind AbCellera's life-saving COVID-19 treatment - The Globe and Mail
E(WHY) Talks interview – Carl Hansen | EY Canada
AbCellera is not a COVID-19 company, CEO insists, even as Canadian developer reaps windfall from pandemic treatments - The Globe and Mail
Carl Hansen, AbCellera CEO sits down with Fierce Biotech's Rebecca Willumson - AbCellera
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
Visionary biotech player Carl Hansen of AbCellera named Canada's EY Entrepreneur Of The Year® 2021 | EY Canada
Carl Hansen
